L Verbist, S Mbete, H Van Landuyt, T Darras, A Gyselen. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdolescentAdultAgedBilirubin/bloodBlood Proteins/analysisDrug Resistance, MicrobialEthambutol/administration & dosageEthambutol/therapeutic useFemaleFollow-Up StudiesHumansIsoniazid/administration & dosageIsoniazid/therapeutic useMaleMiddle AgedMycobacterium tuberculosis/drug effectsMycobacterium tuberculosis/isolation & purificationRadiographyRifampin/administration & dosageRifampin/adverse effectsRifampin/bloodRifampin/pharmacologyRifampin/therapeutic useSputum/microbiologyTransaminases/bloodTuberculosis, Pulmonary/diagnostic imagingTuberculosis, Pulmonary/drug therapyTuberculosis, Pulmonary/microbiology
Substances： See more » Blood ProteinsEthambutolTransaminasesBilirubinIsoniazidRifampin
Year: 1972 PMID： 4624278 DOI： 10.1016/s0012-3692(15)39155-8
Source DB: PubMed Journal: Chest ISSN： 0012-3692 Impact factor: 9.410